Text of US HB 2107 (2025)
Children’s Hospital GME Support Reauthorization Act of 2025
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
8,964 characters
I
119TH CONGRESS
1ST SESSION H. R. 2107
To amend title III of the Public Health Service Act to reauthorize the
program of payments to children’s hospitals that operate graduate med-
ical education programs, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
MARCH 14, 2025
Mr. CRENSHAW (for himself, Mrs. MILLER of Illinois, Mrs. MILLER-MEEKS,
Mr. PFLUGER, Mr. ELLZEY, Mr. VAN DREW, Mr. GREEN of Tennessee,
Mr. ROUZER, Mrs. HARSHBARGER, Mr. GROTHMAN, Mr. JACKSON of
Texas, and Mr. SCOTT FRANKLIN of Florida) introduced the following
bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend title III of the Public Health Service Act to
reauthorize the program of payments to children’s hos-
pitals that operate graduate medical education programs,
and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Children’s Hospital
4
GME Support Reauthorization Act of 2025’’.
5
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB
2
•HR 2107 IH
SEC. 2. PROGRAM OF PAYMENTS TO CHILDREN’S HOS-
1
PITALS THAT OPERATE GRADUATE MEDICAL
2
EDUCATION PROGRAMS.
3
Section 340E of the Public Health Service Act (42
4
U.S.C. 256e) is amended—
5
(1) in subsection (a), by striking ‘‘2023’’ and
6
inserting ‘‘2030’’;
7
(2) in subsection (b)(3)(D), by inserting ‘‘and
8
the end of fiscal year 2030,’’ after ‘‘fiscal year
9
2022,’’;
10
(3) in subsection (e), by adding at the end the
11
following new paragraph:
12
‘‘(4) PROHIBITION
ON
PAYMENTS
TO
HOS-
13
PITALS FURNISHING SPECIFIED PROCEDURES AND
14
DRUGS TO MINORS.—
15
‘‘(A) IN GENERAL.—Notwithstanding any
16
other provision of this section, no payment may
17
be made under this section to a children’s hos-
18
pital for a fiscal year (beginning with fiscal year
19
2026) if, at any point during the preceding fis-
20
cal year, such hospital furnished specified pro-
21
cedures and drugs (as defined in subsection (g))
22
to an individual under 18 years of age.
23
‘‘(B) SPECIAL
RULE
FOR
FISCAL
YEAR
24
2026.—In applying subparagraph (A) with re-
25
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB
3
•HR 2107 IH
spect to payments described in such subpara-
1
graph for fiscal year 2026—
2
‘‘(i) the reference to ‘for a fiscal year’
3
shall be treated as a reference to ‘for any
4
portion of fiscal year 2026 occurring after
5
December 31, 2025’; and
6
‘‘(ii) the reference to ‘the preceding
7
fiscal year’ shall be treated as a reference
8
to ‘the period beginning on September 1,
9
2025, and ending on December 31, 2025’.
10
‘‘(C) RULE OF CONSTRUCTION.—Nothing
11
in this paragraph shall be construed as prohib-
12
iting payments for a fiscal year (or, in the case
13
of payments for fiscal year 2026, during the
14
portion of such fiscal year described in subpara-
15
graph (B)(i)) to a hospital that, during the pre-
16
ceding fiscal year (or, in the case of payments
17
for fiscal year 2026, during the period de-
18
scribed in subparagraph (B)(ii)), furnished
19
mental or behavioral health services to individ-
20
uals under 18 years of age for the treatment of
21
gender dysphoria not consisting of specified
22
procedures and drugs.’’;
23
(4) in subsection (f)—
24
(A) in paragraph (1)(A)—
25
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB
4
•HR 2107 IH
(i) in clause (v), by striking ‘‘and’’ at
1
the end;
2
(ii) in clause (vi), by striking the pe-
3
riod at the end and inserting ‘‘; and’’; and
4
(iii) by adding at the end the fol-
5
lowing:
6
‘‘(vii) for each of fiscal years 2026
7
through 2030, $124,000,000.’’; and
8
(B) in paragraph (2)—
9
(i) in subparagraph (E), by striking
10
‘‘and’’ at the end;
11
(ii) in subparagraph (F), by striking
12
the period at the end and inserting ‘‘;
13
and’’; and
14
(iii) by adding at the end the fol-
15
lowing:
16
‘‘(G) for each of fiscal years 2026 through
17
2030, $261,000,000’’; and
18
(5) in subsection (g), by adding at the end the
19
following new paragraph:
20
‘‘(4) SPECIFIED PROCEDURES AND DRUGS.—
21
‘‘(A) IN GENERAL.—Except as provided in
22
subparagraph (B), the term ‘specified proce-
23
dures and drugs’ means, with respect to an in-
24
dividual, any of the following:
25
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB
5
•HR 2107 IH
‘‘(i) Performing any surgery for the
1
purpose of changing the body of such indi-
2
vidual to no longer correspond to the indi-
3
vidual’s sex, including—
4
‘‘(I) castration;
5
‘‘(II) orchiectomy;
6
‘‘(III) scrotoplasty;
7
‘‘(IV) vasectomy;
8
‘‘(V) hysterectomy;
9
‘‘(VI) oophorectomy;
10
‘‘(VII) ovariectomy;
11
‘‘(VIII) metoidioplasty;
12
‘‘(IX) penectomy;
13
‘‘(X) phalloplasty;
14
‘‘(XI) vaginoplasty;
15
‘‘(XII) vaginectomy;
16
‘‘(XIII) vulvoplasty;
17
‘‘(XIV)
reduction
18
thyrochondroplasty;
19
‘‘(XV) chondrolaryngoplasty, or
20
any plastic surgery that feminizes or
21
masculinizes the facial features;
22
‘‘(XVI)
mastectomy,
or
any
23
placement of chest implants to create
24
feminine breasts; and
25
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB
6
•HR 2107 IH
‘‘(XVII) Any placement of fat or
1
artificial implants in the gluteal re-
2
gion.
3
‘‘(ii) Administering, supplying, pre-
4
scribing, dispensing, distributing, or other-
5
wise conveying to an individual medications
6
for the purposes described in clause (i), in-
7
cluding gonadotrophin releasing hormone
8
(GnRH) analogues or other puberty-block-
9
ing drugs to stop or delay normal puberty,
10
and estrogen, testosterone, progesterone,
11
or other androgens to an individual in an
12
amount greater than would normally be
13
produced endogenously in a healthy indi-
14
vidual of that individual’s age and sex.
15
‘‘(B)
EXCEPTION.—Subparagraph
(A)
16
shall not apply to the provision by a physician
17
or health care provider, with the consent of the
18
child’s parent or legal guardian, of—
19
‘‘(i) puberty suppression or blocking
20
prescription drugs for the purpose of nor-
21
malizing puberty for a minor experiencing
22
precocious puberty;
23
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB
7
•HR 2107 IH
‘‘(ii) appropriate and medically nec-
1
essary procedures or treatments to correct
2
for—
3
‘‘(I) a medically verifiable genetic
4
disorder of sex development, includ-
5
ing—
6
‘‘(aa) 46,XX chromosomes
7
with virilization;
8
‘‘(bb) 46,XY chromosomes
9
with undervirilization; and
10
‘‘(cc) both ovarian and tes-
11
ticular tissue; or
12
‘‘(II) sex chromosome structure,
13
sex steroid hormone production, or
14
sex hormone action, if determined to
15
be abnormal by a physician through
16
genetic or biochemical testing;
17
‘‘(iii) infection, disease, injury, or dis-
18
order caused or exacerbated by previous
19
medical procedures as defined in sub-
20
section (g)(4)(A); or
21
‘‘(iv) a physical disorder, physical in-
22
jury, or physical illness that would, as cer-
23
tified by a physician, place the individual
24
in imminent danger of death or impair-
25
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB
8
•HR 2107 IH
ment of a major bodily function unless the
1
procedure is performed, not including if
2
the procedure or drug is for the purpose
3
described in subsection (g)(4)(A)(i).
4
‘‘(C) SEX.—For purposes of subparagraph
5
(A), the term ‘sex’ means the indication of male
6
or female sex by reproductive potential or ca-
7
pacity, sex chromosomes, naturally occurring
8
sex hormones, gonads, or internal or external
9
genitalia present at birth.’’.
10
Æ
VerDate Sep 11 2014
05:15 Apr 02, 2025
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H2107.IH
H2107
kjohnson on DSK7ZCZBW3PROD with $$_JOB